Renoprotective effect of two dosages of Losartan (L) in a model of crhonic kidney disease (CDK) by nitric oxide inhibition and and salt overload (2010)
- Authors:
- USP affiliated authors: FANELLI, CAMILLA - FM ; ZATZ, ROBERTO - FM ; FUJIHARA, CLARICE KAZUE - FM
- Unidade: FM
- Subjects: ÓXIDO NÍTRICO; SOLUÇÕES ELETROLÍTICAS; MODELOS ANIMAIS; RATOS; DOENÇA CRÔNICA (PREVENÇÃO E CONTROLE); ABLAÇÃO ANIMAL; NEFROPATIAS (PREVENÇÃO E CONTROLE); RESUMOS (EVENTOS)
- Language: Inglês
- Imprenta:
- Source:
- Conference titles: Simpósio "Avanços em Pesquisas Médicas dos Laboratórios de Investigação Médica do Hospital das Clínicas da FMUSP"
-
ABNT
SOUSA, L B et al. Renoprotective effect of two dosages of Losartan (L) in a model of crhonic kidney disease (CDK) by nitric oxide inhibition and and salt overload. Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 26 abr. 2024. , 2010 -
APA
Sousa, L. B., Okabe, C., Sena, C. R., Ventura, B. H., Fanelli, C., Malheiros, D. M. A. C., et al. (2010). Renoprotective effect of two dosages of Losartan (L) in a model of crhonic kidney disease (CDK) by nitric oxide inhibition and and salt overload. Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo. -
NLM
Sousa LB, Okabe C, Sena CR, Ventura BH, Fanelli C, Malheiros DMAC, Zatz R, Fujihara CK. Renoprotective effect of two dosages of Losartan (L) in a model of crhonic kidney disease (CDK) by nitric oxide inhibition and and salt overload. Clinics. 2010 ; 65 S56.[citado 2024 abr. 26 ] -
Vancouver
Sousa LB, Okabe C, Sena CR, Ventura BH, Fanelli C, Malheiros DMAC, Zatz R, Fujihara CK. Renoprotective effect of two dosages of Losartan (L) in a model of crhonic kidney disease (CDK) by nitric oxide inhibition and and salt overload. Clinics. 2010 ; 65 S56.[citado 2024 abr. 26 ] - Losartan (L) and hydrochlorotiazide (H) association (LH) arrests renal inhury in a model of very advanced chronic kidney disease (CKD)
- Losartan (L) and Hydrochlorothiazide (H)Treatment (LH) arrests renal and cardiac injury in advanced chronic kidney disease by mechanisms not entireky dependent on blood pressure
- Furosemide (F) is less effective than hydroclorothiazide (H) as adjuvant to losartan (L) in arresting the nephropathy associated with the 5/6 renal ablation model (NX)
- Associação terapêutica de losartan (L) e hidroclorotiazida (H) previne progressão da lesão renal em modelo de nefropatia crônica resultante da administração de (L) durante a lactação
- Mechanisms of progressive renal injury in adult rats treated with losartan during lactation
- Effects of losartan, in monotherapy or in association with hydrochlorothiazide, in chronic nephropathy resulting from losartan treatment during lactation
- NF-κB activation mediates crystal translocation and interstitial inflammation in adenine overload nephropathy
- Combined Losartan (L) and Hydrocholorothyazide (H) treatment (LH) prevents progression of chronic kidney disease (CKD) resulting from L treatment during lactation (LLac)
- Regressão da nefropatia diabética experimental: Ausência de efeito dose resposta de um antagonista da angiotensina II
- Linking Oxidative Stress, the Renin-Angiotensin System, and Hypertension [Editorial]
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
